2-acetyl-3-furan-2-yl-acrylic acid methyl ester | 164347-14-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 酮酸及其衍生物
• 英文名称: 2-acetyl-3-furan-2-yl-acrylic acid methyl ester
• 英文别名: 2'-furfurylidene acetoacetic acid methyl ester；Methyl 2-(furan-2-ylmethylidene)-3-oxobutanoate
• CAS: 164347-14-2
• 化学式: C₁₀H₁₀O₄
• mdl: MFCD25959800
• 分子量: 194.187
• InChiKey: GFRTTXWBAMWTLW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  56.5
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  乙酰乙酸烯丙酯 、 2-acetyl-3-furan-2-yl-acrylic acid methyl ester 在 conc. ammonia 作用下， 以 乙醇 为溶剂， 以59%的产率得到2,6-dimethyl-4-(2'-furyl)-1,4-dihydropyridine 3,5-dicarboxylic acid 3-methyl ester 5-allyl ester
  参考文献：
  名称：

  Pharmaceutical compositions containing unsymmetrical esters of

  摘要：

  含有不对称酯化的1,4-二氢吡啶-3,5-二羧酸的药物组合物作为活性成分，并使用方法。所述成分是在二氢吡啶核的4位被苯基取代的不对称1,4-二氢吡啶-3,5-二羧酸酯，该苯基含有至少一个硝基、氰基、叠氮基、烷基硫醚或烷基磺酰基取代基。这些组合物具有心血管活性，可用于促进冠状血管扩张，并且在治疗高血压方面具有用途。

  公开号：

  US03932645A1
• 作为产物：
  描述：

  糠醛 、 乙酰乙酸甲酯 在 哌啶 、 溶剂黄146 作用下， 以 苯 为溶剂， 反应 8.0h， 以74%的产率得到2-acetyl-3-furan-2-yl-acrylic acid methyl ester
  参考文献：
  名称：

  A new route to 2-alkenyl-1,3-dicarbonyl compounds, intermediates in the synthesis of dihydrofurans

  摘要：

  A two step synthetic strategy for obtaining 2-alkenyl-1,3-dicarbonyl compounds from the corresponding 1,3-dicarbonyl compounds is reported. The method is based on a Knoevenagel condensation and a Michael addition using a high order organocuprate procedure, and proves to be of general value, Obtained compounds are useful starting materials for the synthesis of furan derivatives, (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(01)01173-5

文献信息

• Syntheses and Spectral Properties of Unsymmetrically 3,5-Disubstituted 2,6-Dimethyl-1,4-dihydropyridines
  作者：Dušan Ilavský、Viktor Milata

  DOI：10.1135/cccc19961233

  日期：——

  Unsymmetrically 3,5-disubstituted 4-(5-X-2-furyl)-2,6-dimethyl-1,4-dihydropyridines (where X = H, Br, NO₂) have been synthesized and characterized by spectral methods (IR, UV, ¹H NMR and MS). The modified Hantzsch method made it possible to prepare the title compounds as well as their N-alkylated derivatives. The paper also describes the N-alkylation of sodium salts of substituted 1,4-dihydropyridines using the phase-transfer catalysis.

  通过光谱方法（红外线、紫外线、1H核磁共振和质谱），合成并表征了非对称3,5-二取代的4-(5-X-2-呋喃基)-2,6-二甲基-1,4-二氢吡啶类化合物（其中X = H、Br、NO2）。改良的Hantzsch方法使得制备了标题化合物及其N-烷基化衍生物成为可能。该论文还描述了使用相转移催化法对取代的1,4-二氢吡啶的钠盐进行N-烷基化的过程。
• Oxazolo[3,2-a]pyridine. A new structural scaffold for the reversal of multi-drug resistance in Leishmania
  作者：Esther Caballero、José Ignacio Manzano、Pilar Puebla、Santiago Castanys、Francisco Gamarro、Arturo San Feliciano

  DOI：10.1016/j.bmcl.2012.07.100

  日期：2012.10

  Compounds belonging to three different classes of fused heterocyclic systems, structurally related to Calcium-channel blockers of the 1,4-dihydropyridine family, were evaluated in their ability to overcome leishmanial resistance to common drugs in a MDR Leishmania tropica strain. Compounds with the skeletal basis of oxazolo[3,2-a]pyridine displayed significant reversion of resistance to daunomycin and miltefosine, with reversion indexes up to 6.7-fold and 8.7-fold, respectively. Most interestingly, the enantiopure compound 20S attained to revert the resistance to both drugs and fairly more significantly than its enantiomer 20R. (C) 2012 Elsevier Ltd. All rights reserved.
• A new route to 2-alkenyl-1,3-dicarbonyl compounds, intermediates in the synthesis of dihydrofurans
  作者：Roberto Antonioletti、Paolo Bovicelli、Savina Malancona

  DOI：10.1016/s0040-4020(01)01173-5

  日期：2002.1

  A two step synthetic strategy for obtaining 2-alkenyl-1,3-dicarbonyl compounds from the corresponding 1,3-dicarbonyl compounds is reported. The method is based on a Knoevenagel condensation and a Michael addition using a high order organocuprate procedure, and proves to be of general value, Obtained compounds are useful starting materials for the synthesis of furan derivatives, (C) 2002 Elsevier Science Ltd. All rights reserved.
• Pharmaceutical compositions containing unsymmetrical esters of
  申请人：Farbenfabriken Bayer AG

  公开号：US03932645A1

  公开（公告）日：1976-01-13

  Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acids as the active ingredient and methods of using same. The said ingredients are unsymmetrical 1,4-dihydropyridine 3,5-dicarboxylates which are substituted at position-4 of the dihydropyridine nucleus by phenyl which contains at least one nitro, cyano, azido, alkylthio, or alkylsulphonyl substituent. The compositions have a cardiovascular activity which makes them useful for effecting coronary vascular dilation and, also, they have utility in the treatment of hypertension.

  含有不对称酯化的1,4-二氢吡啶-3,5-二羧酸的药物组合物作为活性成分，并使用方法。所述成分是在二氢吡啶核的4位被苯基取代的不对称1,4-二氢吡啶-3,5-二羧酸酯，该苯基含有至少一个硝基、氰基、叠氮基、烷基硫醚或烷基磺酰基取代基。这些组合物具有心血管活性，可用于促进冠状血管扩张，并且在治疗高血压方面具有用途。